# EDGAR Filing Document

**Accession Number:** 0001976517
**File Stem:** 0000894189-26-006092
**Filing Date:** 2026-2
**Character Count:** 12329
**Document Hash:** bcaabbdb608154b1076a2f3b9ac6ccb2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000894189-26-006092.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0000894189-26-006092

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**PERIOD START**: 20251231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Roundhill ETF Trust
- **CENTRAL INDEX KEY:** 0001976517

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23887
- **FILM NUMBER:** 26685570

**BUSINESS ADDRESS:**
- **STREET 1:** 154 WEST 14TH STREET
- **STREET 2:** 2ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011
- **BUSINESS PHONE:** 6466615441

**MAIL ADDRESS:**
- **STREET 1:** 154 WEST 14TH STREET
- **STREET 2:** 2ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011

## Series and Classes Contracts Data

### Roundhill GLP-1 & Weight Loss ETF (Series ID: S000085000)

| Class ID   | Class Name                        | Ticker Symbol   |
|:---|:---|:---|
| C000249863 | Roundhill GLP-1 & Weight Loss ETF | OZEM            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Roundhill ETF Trust

- **b. Investment Company Act file number:** 811-23887

- **c. CIK number of Registrant:** 0001976517

- **d. LEI of Registrant:** 5299005P0GRW4PIQ0W17

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 154 West 14th Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10011

  - **Telephone number:** 855-561-5728

**Item A.2. Information about the Series.**

- **a. Name of Series:** Roundhill GLP-1 & Weight Loss ETF

- **b. EDGAR series identifier (if any):** S000085000

- **c. LEI of Series:** 529900AZ7GG1DEFS4J15

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-12-31

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $46658508.52

**Total Liabilities:** $2329404.97

**Net Assets:** $44329103.55

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000249863 | 5.12%                | 16.22%               | 3.69%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $232560.27               | $1500409.13                                |
| Month 2  | $1292677.37              | $4414824.27                                |
| Month 3  | $4367282.13              | $-2777555.82                               |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                                      | Title                                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Amgen Inc                                 | Amgen Inc                                          | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      4855 | NS      | $1589090.05   | 3.58%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                           | AstraZeneca PLC                                    | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     15423 | NS      | $1417836.39   | 3.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                       | Gilead Sciences Inc                                | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      6839 | NS      | $839418.86    | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                          | Novo Nordisk A/S                                   | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    171668 | NS      | $8734467.84   | 19.70%            |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd                         | Shionogi & Co Ltd                                  | CUSIP: N/A<br>LEI: 35380049VXDTHZI3DY35       | Long             | EC               | CORP              | JP        |     34200 | NS      | $619874.32    | 1.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                          | Roche Holding AG                                   | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |      4484 | NS      | $1857556.07   | 4.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                | Pfizer Inc                                         | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |     71190 | NS      | $1772631.00   | 4.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc             | Regeneron Pharmaceuticals Inc                      | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      1630 | NS      | $1258148.10   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                | Rhythm Pharmaceuticals Inc                         | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |      6080 | NS      | $650803.20    | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp                 | Scholar Rock Holding Corp                          | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |     19451 | NS      | $856816.55    | 1.93%             |  |  |  | No            |                  1 | On Loan: —       |
| Structure Therapeutics Inc                | Structure Therapeutics Inc                         | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25981 | NS      | $1806978.55   | 4.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                   | Viking Therapeutics Inc                            | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |     55565 | NS      | $1954776.70   | 4.41%             |  |  |  | No            |                  1 | On Loan: —       |
| Mount Vernon Liquid Assets Portfolio, LLC | Mount Vernon Liquid Assets Portfolio, LLC          | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |   2222059 | NS      | $2222058.75   | 5.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Zealand Pharma A/S                        | Zealand Pharma A/S                                 | CUSIP: N/A<br>LEI: 549300ITBB1ULBL4CZ12       | Long             | EC               | CORP              | DK        |     27496 | NS      | $2016500.16   | 4.55%             |  |  |  | No            |                  1 | On Loan: No      |
| UNITED LAB                                | United Laboratories International Holdings Ltd/The | CUSIP: N/A<br>LEI: 2549007JL3XIH77JXN70       | Long             | EC               | CORP              | HK        |    606000 | NS      | $902362.69    | 2.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Hanmi Pharm Co Ltd                        | Hanmi Pharm Co Ltd                                 | CUSIP: N/A<br>LEI: 988400PP10VZVUOFE672       | Long             | EC               | CORP              | KR        |      4841 | NS      | $1518955.95   | 3.43%             |  |  |  | No            |                  1 | On Loan: No      |
| FOSUN PHARMA                              | Shanghai Fosun Pharmaceutical Group Co Ltd         | CUSIP: N/A<br>LEI: 300300DMUYLW3FP1OT73       | Long             | EC               | CORP              | CN        |    565000 | NS      | $1419123.79   | 3.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascletis Pharma Inc                       | Ascletis Pharma Inc                                | CUSIP: N/A<br>LEI: 254900SKEFCO9I3GPL05       | Long             | EC               | CORP              | CN        |   1026000 | NS      | $1501399.11   | 3.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Innovent Biologics Inc                    | Innovent Biologics Inc                             | CUSIP: N/A<br>LEI: 25490058ONL9SCIE1R22       | Long             | EC               | CORP              | CN        |    142500 | NS      | $1395981.88   | 3.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Gubra A/S                                 | Gubra A/S                                          | CUSIP: N/A<br>LEI: 254900T17RRFZONO6W53       | Long             | EC               | CORP              | DK        |     14172 | NS      | $1153218.76   | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                    | WaVe Life Sciences Ltd                             | CUSIP: N/A<br>LEI: 54930070006GPKFYZ813       | Long             | EC               | CORP              | SG        |     25615 | NS      | $435455.00    | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                            | Eli Lilly & Co                                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      6607 | NS      | $7100410.76   | 16.02%            |  |  |  | No            |                  1 | On Loan: No      |
| CSPC Pharmaceutical Group Ltd             | CSPC Pharmaceutical Group Ltd                      | CUSIP: N/A<br>LEI: 529900M3XQCW234H8O91       | Long             | EC               | CORP              | CN        |    790000 | NS      | $855617.65    | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd              | Chugai Pharmaceutical Co Ltd                       | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |     33400 | NS      | $1756459.22   | 3.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                              | Biohaven Ltd                                       | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |     69585 | NS      | $785614.65    | 1.77%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2026-02-02

**Name of Applicant:** Roundhill ETF Trust

**Signature:** /s/ Justin Katz

**Name of Signer:** Justin Katz

**Title:** VP, Operations